Related Experiment Video
Updated: Jun 3, 2026
07:09
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Jak/Stat pathway in Waldenström's macroglobulinemia.
Lucy S Hodge1, Stephen M Ansell
1Division of Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Clinical Lymphoma, Myeloma & Leukemia
|April 2, 2011
Summary
This study investigates the role of the Jak/Stat pathway in Waldenström's macroglobulinemia (WM). Researchers used Jak/Stat inhibitors to explore how cytokine signaling affects immunoglobulin M (IgM) production in WM patients.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- High immunoglobulin M (IgM) levels cause morbidity in Waldenström's macroglobulinemia (WM).
- The Jak/Stat signaling pathway regulates immunoglobulin production in B cells and is often hyperactive in cancers, promoting proliferation and survival.
- Aberrant cytokine signaling in the tumor microenvironment may persistently activate the Jak/Stat pathway in WM.
Purpose of the Study:
- To define the relationship between Jak/Stat-mediated cytokine signaling and IgM hypersecretion in WM.
- To investigate the potential of targeting the Jak/Stat pathway for WM therapy.
Main Methods:
- Utilized targeted Jak/Stat inhibitors.
- Examined the contribution of aberrant cytokine signaling to IgM production in WM.
Main Results:
- The study explored the impact of Jak/Stat pathway inhibition on IgM secretion.
- Findings provide insights into the mechanisms of IgM overproduction in WM.
Conclusions:
- Targeted inhibition of the Jak/Stat pathway may offer a novel therapeutic strategy for Waldenström's macroglobulinemia.
- Understanding cytokine signaling's role in WM pathogenesis is crucial for developing effective treatments.
Related Concept Videos
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:31Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...